tiprankstipranks
ZyVersa Therapeutics (ZVSA)
OTHER OTC:ZVSA
US Market
ZVSA
ZyVersa Therapeutics
RESEARCH TOOLSreports

ZyVersa Therapeutics (ZVSA) Financial Statements

205 Followers

ZyVersa Therapeutics Financial Overview

ZyVersa Therapeutics's market cap is currently $1.62M. The company's EPS TTM is $-0.43; its P/E ratio is -0.03; ZyVersa Therapeutics is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Mar 23Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -6.93K$ -10.40K$ -10.40K$ -10.40K
Operating Income$ -25.49B$ -9.14B$ -14.42M$ -13.83M$ -7.70M
EBITDA$ -25.49B$ -9.14B$ -107.74M$ -14.43M$ -7.25M
Net Income$ -24.95B$ -9.41B$ -98.30M$ -14.05M$ -8.08M
Balance Sheet
Cash & Short-Term Investments$ 101.78M$ 1.53M$ 3.14M$ 5.90M$ 328.58K
Total Assets$ 347.90M$ 20.60M$ 22.11M$ 118.51M$ 1.13M
Total Debt$ 0.00$ 0.00$ 8.66K$ 108.76K$ 9.15M
Net Debt$ -101.78M$ -1.53M$ -3.13M$ -5.79M$ 8.82M
Total Liabilities$ 12.73B$ 12.08M$ 11.04M$ 18.51M$ 13.63M
Stockholders' Equity$ -12.39B$ 8.52M$ 11.07M$ 99.99M$ -12.50M
Cash Flow
Free Cash Flow$ -5.11B$ -7.56M$ -8.72M$ -1.49M$ -5.08M
Operating Cash Flow$ -5.11B$ -7.56M$ -8.72M$ -4.89M$ -5.08M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 3.69B$ 5.95M$ 5.96M$ 1.87M$ 5.23M
Currency in USD

ZyVersa Therapeutics Earnings and Revenue History

Income Statement >

ZyVersa Therapeutics Debt to Assets

Balance Sheet >

ZyVersa Therapeutics Cash Flow

Cash Flow >

ZyVersa Therapeutics Forecast EPS vs Actual EPS

Earnings >